Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders

NCT01931033 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01931033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01931033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2013
Completion date
February 22, 2016
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asd, autism spectrum disorders, pdd, pervasive developmental disorders